worx11's bm [at least 200 articles] Export

Recent papers added to worx11's library classified by the tag bm. You can also see everyone's bm.

	Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trials. [My Copy] Cancer, Vol. 110, No. 7. (20 August 2007), pp. 1621-1628. by David R R. Buchanan, Ann M M. O'mara, Joseph W W. Kelaghan, Maria Sgambati, Worta McCaskill-Stevens, Lori Minasian posted to bm oncology quality quality_of_life by worx11 on 2007-09-21 17:19:50 as along with 1 person and 1 group suizan XROWXR
	Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom. [My Copy] Clin Ther, Vol. 27, No. 8. (August 2005), pp. 1295-1310. by E. De Cock, J. Hutton, P. Canney, et al.J. J. Body, P. Barrett-Lee, M. P. Neary, G. Lewis posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 20:23:29 as along with 1 group XROWXR
	Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy. [My Copy] Support Care Cancer, Vol. 13, No. 12. (December 2005), pp. 975-986. by E. De Cock, J. Hutton, P. Canney, et al.J. J. Body, P. Barrett-Lee, M. P. Neary, G. Lewis posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 20:21:31 as along with 1 group XROWXR
	The Medicare Prescription Drug Improvement and Modernization Act and the delivery of cancer chemotherapy. [My Copy] Am J Health Syst Pharm, Vol. 64, No. 15 Suppl 10. (1 August 2007) by C. Downs posted to bm medicare medicare_part_d oncology by worx11 on 2007-09-20 20:17:29 as along with 1 group XROWXR
	Formulary issues at a pediatric hospital: experience at Children's National Medical Center. [My Copy] Hosp Formul, Vol. 26, No. 6. (June 1991), pp. 500-510. by G. J. Cohen, S. J. Allen posted to bm formulary oncology outcomes by worx11 on 2007-09-20 20:14:23 as along with 1 group XROWXR
	Many new cancer drugs in the United Kingdom are facing negative NICE rulings. [My Copy] J Clin Oncol, Vol. 25, No. 18. (20 June 2007) by E. Low, posted to bm oncology outcomes by worx11 on 2007-09-20 20:11:50 as along with 1 group XROWXR
	European perspective on the costs and cost-effectiveness of cancer therapies. [My Copy] J Clin Oncol, Vol. 25, No. 2. (10 January 2007), pp. 191-195. by M. F. Drummond, A. R. Mason posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 20:08:00 as along with 1 group XROWXR
	Cost-utility analysis of imatinib mesilate for the treatment of advanced stage chronic myeloid leukaemia. [My Copy] Br J Cancer, Vol. 89, No. 4. (18 August 2003), pp. 634-640. by A. Gordois, P. Scuffham, E. Warren, S. Ward posted to bm cost-utility oncology outcomes by worx11 on 2007-09-20 19:30:11 as along with 1 group XROWXR
	Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis. [My Copy] Health Technol Assess, Vol. 8, No. 28. (July 2004) by K. Dalziel, A. Round, K. Stein, R. Garside, A. Price posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 19:27:43 as along with 1 group XROWXR
	Cost effectiveness of imatinib compared with interferon-alpha or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia. [My Copy] Pharmacoeconomics, Vol. 23, No. 5. (2005), pp. 515-526. by K. Dalziel, A. Round, R. Garside, K. Stein posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 19:27:07 as along with 1 group XROWXR
	Cost-utility analysis of imatinib mesylate for the treatment of chronic myelogenous leukemia in the chronic phase. [My Copy] Clin Ther, Vol. 26, No. 11. (November 2004), pp. 1924-1933. by E. Warren, S. Ward, A. Gordois, P. Scuffham posted to bm cost-utility oncology outcomes by worx11 on 2007-09-20 19:25:17 as along with 1 group XROWXR
	Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service. [My Copy] Clin Ther, Vol. 26, No. 9. (September 2004), pp. 1546-1561. by M. Marchetti, M. Caruggi, G. Colombo posted to bm budget_impact cost-utility oncology outcomes by worx11 on 2007-09-20 19:23:02 as along with 1 group XROWXR
	Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumours. [My Copy] Clin Drug Investig, Vol. 27, No. 2. (2007), pp. 85-93. by D. M. Huse, M. von Mehren, G. Lenhart, et al.H. Joensuu, C. Blanke, W. Feng, S. Finkelstein, G. Demetri posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 19:21:12 as along with 1 person and 1 group Terkko XROWXR
	Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer. [My Copy] Clin Breast Cancer, Vol. 7, No. 8. (June 2007), pp. 608-618. by T. E. Delea, J. Karnon, O. Sofrygin, S. K. Thomas, N. L. Papo, V. Barghout posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 19:18:02 as along with 1 group XROWXR
	Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: the UK perspective. [My Copy] Pharmacoeconomics, Vol. 24, No. 3. (2006), pp. 237-250. by J. Karnon, T. Delea, S. R. Johnston, et al.R. Smith, J. Brandman, J. Sung, P. E. Goss posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 19:16:06 as along with 1 group XROWXR
	Cost utility analysis of first-line hormonal therapy in advanced breast cancer: comparison of two aromatase inhibitors to tamoxifen. [My Copy] Am J Clin Oncol, Vol. 26, No. 3. (June 2003), pp. 289-296. by G. Dranitsaris, S. Verma, M. Trudeau posted to bm cost-utility oncology by worx11 on 2007-09-20 19:15:12 as along with 1 group XROWXR
	Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole. [My Copy] Breast, Vol. 16, No. 3. (June 2007), pp. 252-261. by C. Skedgel, D. Rayson, R. Dewar, T. Younis posted to bm cost-utility oncology outcomes by worx11 on 2007-09-20 19:02:57 as along with 1 group XROWXR
	Reimbursement for cancer treatment: coverage of off-label drug indications. [My Copy] J Clin Oncol, Vol. 24, No. 19. (1 July 2006), pp. 3206-3208. by posted to bm oncology by worx11 on 2007-09-20 18:57:10 as along with 1 group XROWXR
	Cost considerations in the management of cancer in the older patient. [My Copy] Oncology (Williston Park), Vol. 21, No. 7. (June 2007) by J. M. McKoy, K. A. Fitzner, B. J. Edwards, et al.M. Alkhatib, C. C. Tigue, N. J. Nonzee, C. R. Bolden, C. L. Bennett posted to bm oncology outcomes by worx11 on 2007-09-20 18:54:02 as along with 1 group XROWXR
	Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate. [My Copy] Am J Manag Care, Vol. 13, No. 6 Pt 2. (June 2007), pp. 347-352. by D. E. Mager, E. R. Cox posted to benefit_design bm by worx11 on 2007-09-20 17:46:48 as along with 1 group XROWXR
	Health plans' strategies for managing outpatient specialty pharmaceuticals. [My Copy] Health Aff (Millwood), Vol. 25, No. 5. (t 2006), pp. 1332-1339. by C. D. Mullins, D. C. Lavallee, F. G. Pradel, A. R. DeVries, N. Caputo posted to benefit_design bm by worx11 on 2007-09-20 15:58:39 as along with 1 person and 1 group NCCNHealthPolicyGroup XROWXR
	Pharmacy benefit caps and the chronically ill. [My Copy] Health Aff (Millwood), Vol. 26, No. 5. (t 2007), pp. 1333-1344. by G. F. Joyce, D. P. Goldman, P. Karaca-Mandic, Y. Zheng posted to benefit_design bm by worx11 on 2007-09-20 15:45:58 as along with 1 group XROWXR
	Major changes in benefit design: a plausible way to control costs? [My Copy] Find Brief, Vol. 9, No. 6. (November 2006), pp. 1-6. by C. Demchak posted to benefit_design bm by worx11 on 2007-09-20 15:30:28 as along with 1 group XROWXR
	Insurers' strategies for managing the use and cost of biopharmaceuticals. [My Copy] Health Aff (Millwood), Vol. 25, No. 5. (t 2006), pp. 1205-1217. by J. C. Robinson posted to benefit_design bm by worx11 on 2007-09-20 15:27:18 as along with 1 person and 1 group NCCNHealthPolicyGroup XROWXR
	Employer benefit design considerations for the era of biotech drugs. [My Copy] J Occup Environ Med, Vol. 49, No. 6. (June 2007), pp. 626-632. by F. R. Vogenberg, J. P. Holland, D. Liebeskind posted to benefit_design bm by worx11 on 2007-09-20 15:22:55 as along with 1 group XROWXR
	Specialty pharmacy cost management strategies of private health care payers. [My Copy] J Manag Care Pharm, Vol. 12, No. 9. (c 2006), pp. 736-744. by D. Stern, D. Reissman posted to benefit_design bm by worx11 on 2007-09-20 15:19:38 as along with 1 group XROWXR
	Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy. [My Copy] J Manag Care Pharm, Vol. 13, No. 3. (April 2007), pp. 235-244. by K. Yokoyama, W. Yang, R. Preblick, F. Frech-Tamas posted to benefit_design bm by worx11 on 2007-09-20 15:18:19 as along with 1 group XROWXR
	Controlling prescription drug expenditures: a report of success. [My Copy] Am J Manag Care, Vol. 13, No. 8. (August 2007), pp. 473-480. by D. P. Miller, C. D. Furberg, R. H. Small, et al.F. M. Millman, W. T. Ambrosius, J. S. Harshbarger, C. A. Ohl posted to benefit_design bm by worx11 on 2007-09-20 15:16:53 as along with 1 group XROWXR
	Effects of benefit design change across 5 disease states. [My Copy] Am J Manag Care, Vol. 13, No. 6 Pt 2. (June 2007), pp. 370-376. by D. I. Brixner, V. N. Joish, G. M. Odera, S. G. Avey, D. M. Hanson, H. E. Cannon posted to benefit_design bm by worx11 on 2007-09-20 15:14:00 as along with 1 group XROWXR
	Incentive formularies and changes in prescription drug spending. [My Copy] Am J Manag Care, Vol. 13, No. 6 Pt 2. (June 2007), pp. 360-369. by B. E. Landon, M. B. Rosenthal, S. L. Normand, et al.C. Spettell, A. Lessler, H. R. Underwood, J. P. Newhouse posted to benefit_design bm by worx11 on 2007-09-20 15:12:45 as along with 1 group XROWXR
	Patient-centered management of complex patients can reduce costs without shortening life. [My Copy] Am J Manag Care, Vol. 13, No. 2. (February 2007), pp. 84-92. by L. Sweeney, A. Halpert, J. Waranoff posted to benefit_design bm by worx11 on 2007-09-20 15:11:07 as along with 1 group XROWXR
	Innovations to preserve quality and contain cost. [My Copy] Am J Manag Care, Vol. 12 Spec no. (December 2006) by S. Nicholson posted to benefit_design bm by worx11 on 2007-09-20 15:09:34 as along with 1 group XROWXR
	Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care. [My Copy] Am J Manag Care, Vol. 12, No. 11. (November 2006), pp. 678-683. by D. A. Taira, K. S. Wong, F. Frech-Tamas, R. S. Chung posted to benefit_design bm by worx11 on 2007-09-20 15:08:03 as along with 1 group XROWXR
	Health plan pay-for-performance strategies. [My Copy] Am J Manag Care, Vol. 12, No. 9. (September 2006), pp. 537-542. by S. Trude, M. Au, J. B. Christianson posted to benefit_design bm by worx11 on 2007-09-20 15:04:10 as along with 1 group XROWXR
	Prescription drug cost sharing: associations with medication and medical utilization and spending and health. [My Copy] JAMA, Vol. 298, No. 1. (4 July 2007), pp. 61-69. by D. P. Goldman, G. F. Joyce, Y. Zheng posted to benefit_design bm by worx11 on 2007-09-20 15:02:13 as along with 1 group XROWXR
	Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. [My Copy] Journal of general internal medicine, Vol. 22, No. 9. (September 2007), pp. 1298-1304. by W. H. Shrank, M. Stedman, S. L. Ettner, et al.D. DeLapp, J. Dirstine, M. A. Brookhart, M. A. Fischer, J. Avorn, S. M. Asch posted to benefit_design bm by worx11 on 2007-09-20 15:01:07 as along with 1 person and 1 group kward XROWXR
	Current trends in pharmacy benefit designs: a threat to disease management in chronic complex diseases. [My Copy] Dis Manag, Vol. 10, No. 2. (April 2007), pp. 74-82. by G. Owens, M. F. Emons, J. Christian-Herman, G. Lawless posted to benefit_design bm by worx11 on 2007-09-20 15:00:41 as along with 1 group XROWXR
	Benefit design and specialty drug use. [My Copy] Health Aff (Millwood), Vol. 25, No. 5. (t 2006), pp. 1319-1331. by D. P. Goldman, G. F. Joyce, G. Lawless, W. H. Crown, V. Willey posted to benefit_design bm by worx11 on 2007-09-20 15:00:08 as along with 1 group XROWXR
	Benefit design innovations: implications for consumer-directed health care. [My Copy] Issue Brief Cent Stud Health Syst Change, No. 109. (February 2007), pp. 1-6. by H. T. Tu, P. B. Ginsburg posted to benefit_design bm by worx11 on 2007-09-20 14:59:06 as along with 2 people and 2 groups jcress410 ulrichs XROWXR CHI
	Meeting the Long-Term Care Needs of the Baby Boomers: How Changing Families Will Affect Paid Helpers and Institutions [My Copy] (May 2007) by Richard W. Johnson, Desmond Toohey, Joshua M. Wiener posted to bm caregiving home_healthcare long_term_care senior_care_research by worx11 on 2007-08-09 15:07:44 as along with 1 group XROWXR
	The Burden of Caring for Frail Parents: testimony to Congress [My Copy] (May 2007) by Johnson Rw posted to bm caregiving home_healthcare senior_care_research by worx11 on 2007-08-09 15:05:01 as along with 1 group XROWXR
	A Proposal to Finance Long-Term Care Services through Medicare with an Income Tax Surcharge [My Copy] (June 2007) by Leonard E. Burman, Richard W. Johnson posted to bm caregiving home_healthcare long_term_care medicare medicare_part_d senior_care_research by worx11 on 2007-08-09 15:02:57 as along with 1 group XROWXR
	Caregiver Guide: Module 10: Community Supports for remaining at home [My Copy] (December 2006) by Ucare posted to bm caregiving senior_care_research by worx11 on 2007-08-09 15:01:02 as along with 1 group XROWXR
	United States Health Workforce Profile [My Copy] (October 2006) by Nychealthworkforcestudies posted to bm home_healthcare senior_care_research by worx11 on 2007-08-09 14:54:50 as along with 1 group XROWXR
	CMS Proposes Payment Changes for Medicare Home Health Service [My Copy] (April 2007) by Cms posted to bm home_healthcare senior_care_research by worx11 on 2007-08-09 14:50:05 as along with 1 group XROWXR
	Genworth Financial 2007 Cost of Care Survey: Home Care Providers, Assisted Living Facilities and Nursing Homes [My Copy] (March 2007) by Genworthfinancial posted to assisted_living bm home_healthcare nursing_facility nursing_home senior_care_research by worx11 on 2007-08-09 14:47:56 as along with 1 group XROWXR
	The MetLife Market Survey of Nursing Home and Health Care Costs [My Copy] (September 2006) by Metlife posted to bm home_healthcare medicare medicare_part_d nursing_facility nursing_home senior_care_research by worx11 on 2007-08-09 14:46:05 as along with 1 group XROWXR
	Understanding Medicaid’s Role for the Elderly and Disabled [My Copy] (November 2005) by E. Obrien posted to bm caregiving home_healthcare medicaid medicare medicare_part_d senior_care_research by worx11 on 2007-08-09 14:44:05 as along with 1 group XROWXR
	National Health Expenditure Projections 2006-2016: Forecast Summary [My Copy] (2007) by Cms posted to bm home_healthcare medicare medicare_part_d senior_care_research by worx11 on 2007-08-09 14:42:25 as along with 1 group XROWXR
	Medicare at a glance [fact sheet] [My Copy] (February 2007) by Kff posted to bm home_healthcare medicare medicare_part_d senior_care_research by worx11 on 2007-08-09 14:40:34 as along with 1 group XROWXR

Note: You may cite this page as: http://www.citeulike.org/user/worx11/tag/bm

Result page: 1 2 3 4 5 Next

diabetes	390
me	337
bm	247
lg	207
sm_dossier	206
senior_care_research	169
hiv	164
lipodystrophy	151
economic	70
medicare	70
as	67
medicare_part_d	59
glargine	52
long_term_care	51
cost-effectiveness	48
skilled_nursing_facility	47
snf	46
nursing_facility	44
nursing_home	42
jmcp_manuscript	39
cmrf	37
home_healthcare	31
assisted_living	27
depression	24
zt	21
benefit_design	20
copd	20
oncology	19
caregiving	18
smoking_cessation	18
outcomes	16
type_1_diabetes	16
mm	15
pediatrics	15
pa_research	14
hospital	13
medication_therapy_management	13
quality	13
medicaid	11
mtm	9
ac	6
chemoprevention	6
serm	6
ahrq	5
cost-utility	5
cr_supplement	5
statin	5
asthma	3
pharmacist	3
quality_of_life	3
regulatory	3
standard_of_care	3
derm	2
formulary	2
budget_impact	1
consumers	1
cost_benefit	1
disease_management	1
drug_trends	1
evidence_based	1
exenatide	1
generic	1
osteoporosis	1
pa_researcj	1
pipeline	1
rehabilitation	1
senior_care_research_home_healthcare	1

worx11's bm [at least 200 articles] Export

worx11's tags